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Role of CD8b Domains in CD8 Coreceptor Function:
Importance for MHC I Binding, Signaling, and
Positive Selection of CD81 T Cells in the Thymus
Teh et al., 1988; Kaye et al., 1989). Current models of
CD4 and CD8 coreceptor function propose that surface
coreceptors bind to the same MHC/peptide complexes
as do surface TCR complexes (hence their designation
as coreceptors) (Janeway, 1989; Salter et al., 1990; In-
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signaling by stabilizing interactions between TCR andBethesda, Maryland 20892
MHC/peptide complexes as well as by juxtaposing³ Vaccine Center Yerkes
MHC-engaged TCR complexes with intracellular signal-Emory University
ing intermediates (Veillette et al., 1988; Barber et al.,Atlanta, Georgia 30329
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Although both CD4 and CD8 molecules function asNCI-Frederick Cancer Research and
coreceptors, they are strikingly different moleculesDevelopment Center
(Parnes, 1989). Indeed, CD4 is a single-chain polypep-Frederick, Maryland 21702
tide, whereas CD8 is expressed on the cell surface of
thymically derived CD81 T cells as a complex of CD8a
and CD8b, which are the products of two closely linkedSummary
but separate genes (Ledbetter et al., 1981; Zamoyska
et al., 1985; Liaw et al., 1986; Nakauchi et al., 1987;The contribution of the CD8b subunit to CD8 corecep-
Gorman et al., 1988; Nakayama et al., 1989a). CD8ator function is poorly understood. We now demon-
and CD8b are both members of the immunoglobulin-strate that the CD8b extracellular domain increases
like superfamily and are of similar overall organization,the avidity of CD8 binding to MHC I, and that the intra-
although they display only moderate sequence homol-cellular domain of CD8b enhances association with
ogy. However, CD8a and CD8b play clearly asymmetrictwo intracellular molecules required for TCR signal
roles in CD8 surface expression. That is, surface expres-transduction, Lck and LAT. By assessing CD81 T cell
sion of CD8b requires association with CD8a, as CD8bdifferentiation in CD8b-deficient mice reconstituted
polypeptides are otherwise retained in the endoplasmicwith various transgenic CD8b chimeric molecules, we
reticulum and degraded (Blanc et al., 1988; Gorman etalso demonstrate that the intracellular and extracellu-
al., 1988; Norment and Littman, 1988); whereas CD8alar domains of CD8b can contribute independently to
polypeptides can be expressed at the cell surface with-CD81 T cell development, but that both CD8b domains
out CD8b as CD8aa homodimers (Goodman and Lefran-together are most efficient. Thus, this study identifies
cois, 1988; Baume et al., 1990; Guy-Grand et al., 1991;the molecular functions of the CD8b intracellular and
Rocha et al., 1991).extracellular domains and documents their contribu-
Because CD8 complexes on the surface of thymicallytions to CD81 T cell development.
derived CD81 T cells contain both CD8a and CD8b, it
is tempting to consider that CD8b importantly contrib-Introduction
utes to CD8 coreceptor function in these cells. Indeed,
CD8b contributes in the thymus to the generation ofT lymphocytes are triggered by engagement of their
CD81 T cells and enhances the biological functions ofT cell antigen receptor (TCR) complexes by antigenic
MHC I±restricted mature T cells (Karaki et al., 1992;
peptides associated to major histocompatibility com-
Wheeler et al., 1992, 1998; Crooks and Littman, 1994;
plex (MHC) molecules (Janeway and Bottomly, 1994;
Fung-Leung et al., 1994; Nakayama et al., 1994; Renard
Weiss and Littman, 1994). In general, TCR signaling also et al., 1996). However, the molecular mechanisms by
depends on MHC-induced coengagement of surface which CD8b promotes CD8 coreceptor function have
coreceptor molecules, either CD4 or CD8, which bind not yet been elucidated, as CD8a by itself can interact
to invariant determinants on MHC class II and class I with all molecules currently known to be involved in
molecules, respectively (Doyle and Strominger, 1987; CD8 function. Indeed, CD8aa complexes lacking CD8b
Norment et al., 1988; Parnes, 1989; Potter et al., 1989; directly bind to MHC I with sufficient affinity to be crystal-
Salter et al., 1989). Expression of CD4 or CD8 corecep- lized (Gao et al., 1997; Kern et al., 1998). While it might
tors on mature T cells is mutually exclusive and is con- be hypothesized that CD8aa complexes have lower af-
cordant with the MHC specificity of their TCR. That is, finity for MHC I molecules than do CD8ab complexes,
CD4 is expressed by T cells with TCR specific for MHC plasmon resonance analyses of CD8/MHC I interactions
class II molecules (MHC II), whereas CD8 is expressed have found in fact that CD8aa homodimers bind MHC
by T cells with TCR specific for MHC class I molecules I molecules with similar affinities and kinetics as do
(MHC I). This concordance between coreceptor pheno- CD8ab heterodimers (Garcia et al., 1996; Kern et al.,
type and TCR specificity is imposed during thymic selec- 1999; Wyer et al., 1999). Importantly, however, these
tion of CD4181 precursor thymocytes (Sha et al., 1988; plasmon resonance studies were necessarily performed
on CD8 molecules lacking their plasma membrane at-
tachment and so they may not have been in the samek To whom correspondence should be addressed (e-mail: singera@
nih.gov). orientation as they are on the surface of CD81 T cells.
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In the present study, we examined the role of CD8b
in CD8 coreceptor function by reconstituting CD8b0
mice with transgenes encoding mutant CD8 complexes
that specifically lacked the CD8b extracellular domain,
the CD8b intracellular domain, or both. We used these
mice to analyze the role of CD8b in CD8 binding to
extracellular MHC I molecules and intracellular signaling
molecules. Using a novel assay to assess binding of
MHC I molecules to membrane-associated CD8 com-
plexes, we demonstrate that CD8b critically enhances
MHC I binding to CD8 and that this effect is mediated
by the extracellular domain of CD8b. We also report that
CD8b promotes CD8 binding of intracellular Lck and
LAT signaling molecules and that this effect is mediated
by the intracellular domain of CD8b. Finally, we analyze
in vivo CD8 coreceptor function in positive selection of
Figure 1. Schematic Representation of CD8 Derivatives Used in theCD81 T cells in the thymus. We demonstrate that the
Present Studyextracellular and intracellular domains of CD8b can in-
Mouse CD8a (aaa) and CD8b (bbb) molecules are schematicallydependently promote positive selection of CD81 T cells,
depicted by solid or hatched symbols and designated by a threebut that full reconstitution of CD8 coreceptor function
letter code indicating the origin of their extracellular, transmembranerequires both CD8b domains.
(tmb), and intracellular domains. In addition to cDNAs encoding
intact coreceptor molecules (aaa, bbb), we constructed a cDNA
Results encoding CD8b molecules lacking an intracellular domain (bb0) and
a cDNA encoding a chimeric CD8a/b molecule with the extracellular
domain of CD8a but the transmembrane and intracellular domainsTo gain insight into the function of CD8b, we have exam-
of CD8b (abb). Both aaa and abb cDNAs encoded CD8a.1 mole-ined the role of CD8b in (1) CD8 binding to extracellular
cules, so that they could be distinguished from endogenously en-
MHC I molecules, (2) CD8 binding to intracellular Lck coded CD8a.2 molecules in the mice used in the present study. All
and LAT signaling molecules, and (3) CD8 coreceptor cDNAs were introduced in an hCD2-based transgenic vector that
function, as assessed by positive selection of CD81 T directs expression in immature thymocytes and in mature T cells.
Microinjections were carried out in wild-type (CD8b1/1) zygotes, andcells in the thymus. To this end, we introduced into
offspring of the transgenic founders were subsequently made CD8b0CD8b0 mice a series of transgenes encoding wild-type
by breeding with CD8b0 mice. In CD8b0 thymocytes, transgene-or mutant CD8 proteins that pair with endogenous CD8a
encoded molecules pair with endogenous CD8a molecules to form
molecules, resulting in surface expression of either wild- CD8 complexes as schematically depicted.
type CD8ab complexes or variant CD8 complexes lack-
ing the intracellular or extracellular domains of CD8b,
or both (see Figure 1 for a schematic of the transgenes which three were bound by more than 50% of thymo-
used in this study). We thus generated CD8b0 mice that cytes and one of which was used for the present study
expressed (1) wild-type CD8b molecules (referred to as and consisted of H-2Dk, human b2-microglobulin, and
bbb), (2) wild-type CD8a molecules (referred to as aaa), a 9 amino acid peptide derived from the polyoma virus
(3) tailless CD8b molecules lacking the CD8b intracellu- middle T antigen (MT389) (Wilson et al., 1999) (Figure
lar domain (referred to as bb0), or (4) chimeric CD8 mole- 2A). Note that tetramer binding occurred at 48C and only
cules whose extracellular domain was from CD8a and on CD81 thymocytes but not CD82 thymocytes (Table
whose transmembrane and intracellular domains were 1; Figure 2A, right). In fact, MHC I tetramers bound at
from CD8b (referred to as abb). 48C to surface CD8 complexes but not to surface TCR
complexes, as shown by the facts that (1) TCRa-defi-
cient (TCRa0) thymocytes, which lack surface TCR com-The CD8b Extracellular Domain Enhances CD8
Binding to MHC Class I Molecules plexes, bound MHC I tetramers as efficiently as wild-
type thymocytes (Figure 2A); (2) CD8a-deficient (CD8a0)Because CD8 coreceptor function is dependent on the
ability of CD8 molecules to bind to MHC I molecules, it thymocytes, which lack surface CD8 complexes, failed
to bind MHC I tetramers (Figure 2A); and (3) MHC Iis conceivable that CD8b enhances CD8 binding of MHC
I molecules. A direct assessment of this possibility has tetramer binding to thymocytes was inhibited by prein-
cubation of thymocytes with anti-CD8a or anti-CD8bproven difficult, as MHC I/CD8 interactions are of low
affinity and follow extremely rapid exchange kinetics blocking monoclonal antibodies (mAb) (Figure 2B, upper
panel). To rule out a role for any T cell±specific surface(Garcia et al., 1996; Kern et al., 1999; Wyer et al., 1999).
However, we thought that tetramers of MHC I molecules component other than CD8 in MHC I tetramer binding,
we examined MHC I tetramer binding to HeLa cells(Altman et al., 1996), because of their potential for
multivalent binding, might be able to bind to CD8 surface transfected with expression vectors for mouse CD8a
and CD8b. As shown in Figure 2B (lower panel), MHC Icomplexes with sufficient avidity to be detected. Conse-
quently, we assessed a variety of MHC I tetramers, ob- tetramers bound to CD8ab2transfected HeLa cells but
not to untransfected HeLa cells. Thus, MHC I tetramerstained by coupling biotinylated MHC I/peptide com-
plexes to fluorochrome-labeled streptavidin molecules, specifically bind to cell surface CD8 complexes.
Using this assay to compare MHC I binding to CD8aafor their binding to the surface of mouse thymocytes.
We examined five different MHC I/peptide tetramers, of versus CD8ab complexes, we examined MHC I tetramer
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levels of CD8a on the surface of CD8b0 thymocytes,
as introduction of the aaa transgene increased CD8a
surface expression to 160% of that on wild-type thymo-
cytes but only marginally improved MHC I tetramer bind-
ing. In contrast, expression of the bbb transgene
strongly increased MHC I tetramer binding to levels simi-
lar to those observed in wild-type thymocytes. These
results show that CD8b significantly enhances the ability
of surface CD8 complexes to bind MHC I molecules.
To identify the CD8b domain responsible for increased
MHC I binding, we compared MHC I tetramer binding
to CD8b0 thymocytes expressing either the bb0 or the
abb transgene. In CD8b0 thymocytes, expression of the
bb0 transgene fully reconstituted MHC I tetramer bind-
ing, whereas expression of the abb transgene did not.
Thus, the CD8b extracellular domain promotes CD8
binding to MHC I.
The Intracellular Domain of CD8b Promotes LAT
and Lck Association to CD8a
We next examined the role of CD8b in interactions be-
tween surface CD8 complexes and the intracellular sig-
naling molecules Lck and LAT. While association of Lck
and LAT with CD8 requires binding motifs present within
the CD8a intracellular domain (Shaw et al., 1990; Turner
et al., 1990; Bosselut et al., 1999), both are markedly
enhanced by CD8b (Irie et al., 1995, 1998; Bosselut et
al., 1999). To map this function of CD8b, we assessed
the amount of Lck and LAT in CD8 immunoprecipitates
prepared from either CD8b0 thymocytes or from CD8b0
thymocytes expressing mutant CD8 transgenes (Figure
4A). This experiment confirmed that CD8b promotes Lck
and LAT association to CD8 (Figure 4A, lanes 1 and 2)
and demonstrated that the intracellular domain of CD8b
is responsible for this effect (Figure 4A, lanes 3±6). That
is, CD8/Lck and CD8/LAT associations were decreased
in thymocytes whose CD8 complexes lacked the CD8b
Figure 2. MHC I Tetramers Bind Surface CD8 Complexes
intracellular domain (i.e., CD8b0 thymocytes and CD8b0
(A) Thymocytes from wild-type (B6), TCRa0, or CD8a0 mice were
thymocytes expressing the aaa or bb0 transgenes).stained at 4oC with H-2Dk MHC I tetramers, followed by anti-CD4
Conversely, expression of the abb or bbb transgenesand anti-CD8a mAbs. Single-color histograms of MHC I tetramer
in CD8b0 thymocytes restored CD8/Lck and CD8/LATbinding (solid line) are shown in the middle column. Two-dimen-
sional contour plots for CD4 and CD8 surface expression are shown associations to wild-type levels. Thus, the CD8b intra-
on all cells (left column), or on cells electronically gated for tetramer cellular domain promotes association of Lck and LAT
binding (right column). Shaded curves represent background fluo- to surface CD8 complexes.
rescence of cells not exposed to MHC I tetramers. Numbers indicate
To show that decreased association with intracellularthe percentage of tetramer1 thymocytes.
signaling molecules diminishes CD8-dependent TCR(B) Thymocytes from wild-type mice were stained with H-2Dk tetra-
signal transduction, we examined tyrosine phosphoryla-mer and analyzed by flow cytometry (upper panel, solid line). Alter-
natively, thymocytes were first incubated with unconjugated mAbs tion in thymocytes signaled by antibody-mediated coen-
against CD8a (53.6±7) or CD8b (53.5±8) prior to staining with H-2Dk gagement of surface TCR and CD8 complexes. Coen-
tetramer (upper panel, shaded histogram). Preincubation with anti- gagement of TCR with either CD4 or CD8 induced
CD8a or anti-CD8b mAbs reduced MHC I tetramer binding to back-
tyrosine phosphorylation of TCRz and ZAP70 in devel-ground levels (upper panel, shaded histogram).
oping thymocytes, neither of which occurred in re-HeLa cells were transiently transfected with expression vectors for
sponse to TCR engagement alone (Wiest et al., 1996;CD8a and CD8b (lower panel). Forty hours later, separate aliquots
of cells were stained with H-2Dk tetramers, anti-CD8a, or anti-CD8b Figure 4B). However, unlike TCR 1 CD4 coengagement
mAbs and analyzed by flow cytometry. Single-color histograms that induced equivalent amounts of TCRz and ZAP70
(lower panel, solid lines) are shown for each staining. No staining was tyrosine phosphorylation in CD8b0 and wild-type thymo-
detected on untransfected cells (lower panel, shaded histograms).
cytes (Figure 4B, lanes 3 and 7), TCR 1 CD8 coengage-
ment induced 60% less TCRz and ZAP70 tyrosine phos-
phorylation in CD8b0 thymocytes relative to wild-typebinding to wild-type and CD8b0 thymocytes by quanti-
tating tetramer-associated surface fluorescence. As thymocytes (Figure 4B, lanes 4 and 8). Thus, CD8b is
specifically required for efficient TCR signal transduc-shown in Figure 3, the level of MHC I tetramer binding
was 50-fold greater on wild-type thymocytes than on tion induced by coengagement of TCR and CD8 surface
complexes.CD8b0 thymocytes. This difference was not due to lower
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Table 1. Temperature Dependence of MHC I Tetramer Binding to Surface CD8 Complexes
B6 Thymocytes CD8b0 Thymocytes
Binding
Tetramer Temperaturea Percent Positiveb Fluorescence Intensityc Percent Positiveb Fluorescence Intensityc
H-2Dk 48C 72 293 2 ,1
H-2Dk 378C 31 11 2 ,1
a MHC I tetramers were incubated with thymocytes for 1 hr at the indicated temperature. Cells were then transferred at 48C and immediately
washed to remove unbound tetramers. All washes were performed at 48C, regardless of the temperature used for the binding reaction.
b Percent of total thymocytes.
c Fluorescence intensity was quantitated as total fluorescence units (TFU 3 1024).
Role of the Intracellular and Extracellular Domains with wild-type or variant CD8 transgenes. CD81 T cell
differentiation was severely compromised in CD8b0 miceof CD8b in Intrathymic CD81 T Cell Differentiation
So far, we have shown that the CD8b extracellular do- as the number of mature CD81 thymocytes in CD8b0
mice was reduced to 20%±25% of that in wild-type micemain promotes CD8/MHC I interaction, and that the
CD8b intracellular domain promotes CD8 association (Figure 5), as previously reported (Crooks and Littman,
1994; Fung-Leung et al., 1994). Importantly, increasedwith Lck and LAT. Our next objective was to assess
the importance of these two CD8b domains for CD8 CD8a expression did not compensate for the absence
of CD8b during CD81 T cell differentiation, as CD81 Tcoreceptor function. To this end, we examined intra-
thymic T cell differentiation in CD8b0 mice reconstituted cell differentiation was fully restored in CD8b0 mice by
the bbb transgene but was not improved by the aaa
transgene (Figure 5). To map the domains of CD8b re-
quired for this function, we analyzed CD81 T cell differ-
entiation in CD8b0 mice expressing bb0 or abb trans-
genes (Figure 5). While expression of the bb0 transgene
significantly increased CD81 T cell generation, neither
the bb0 transgene nor the abb transgene could fully
restore CD81 T cell differentiation in CD8b0 mice, show-
ing that both the extracellular and intracellular domains
of CD8b are important for CD8 coreceptor function.
Analysis of the role of the CD8b intracellular and extra-
cellular domains in CD81 T cell differentiation was ham-
pered in non-TCR transgenic mice by relatively low num-
bers of CD4281 thymocytes. To overcome this difficulty,
we examined CD81 T cell differentiation in mice express-
ing the HY TCR transgene, as the HY TCR selects large
numbers of thymocytes into the CD81 T cell lineage (Teh
et al., 1988). In female mice expressing H-2Db-selecting
MHC I molecules, cells positively selected by the HY
TCR upregulate surface expression of the clonotypic
HY TCR and can be identified by their high expression
of the T3.70 clonotypic epitope. Thus, in HY TCR trans-
genic mice, CD4281 thymocytes are T3.70hi, indicating
that they have been positively selected by the HY trans-
genic TCR, whereas CD4182 thymocytes are T3.70lo, as
they have been selected on endogenously rearranged
TCRs. Importantly, positive selection of CD81 T cells by
the HY TCR was almost completely abolished in the
absence of CD8b (Crooks and Littman, 1994; Figure 6)
Figure 3. The CD8b Extracellular Domain Increases CD8/MHC I and was restored by the bbb transgene but only mini-
Binding mally by the aaa transgene (Figure 6). Thus, positive
Thymocytes from CD8b1/1 (B6) or CD8b0 animals or from CD8b0 selection by the HY TCR is highly dependent on CD8b
animals expressing the indicated transgenes were analyzed by sur-
and provides a sensitive assay for CD8b function. Weface staining and flow cytometry. Surface expression of CD8b and
observed that expression of either bb0 transgene (ex-CD8a (both transgenic CD8a.1 and endogenous CD8a.2 molecules)
pressing the CD8b extracellular domain) or abb trans-(solid lines) are shown relative to control staining (shaded). Staining
intensities (total fluorescence) were quantified using a calibration gene (expressing the CD8b intracellular domain) markedly
curve empirically derived for the logarithmic amplifier used and were increased the numbers of CD4281T3.70hi thymocytes in
expressed in relative fluorescence units (RFU), set at 100 for CD81 HY CD8b0 mice, although neither of them functioned as
thymocytes in wild-type mice. Cells were stained with H-2Dk tetra- efficiently as wild-type CD8b (bbb). Thus, these observa-
mer complexes alone (right column, solid lines) and total fluores-
tions demonstrate that the extracellular domain of CD8bcence was quantified in total fluorescence units (TFU). Background
can enhance CD8 coreceptor function in the absencefluorescence of cells not exposed to MHC I tetramer is shown for
each strain (right column, shaded histogram). of the CD8b intracellular domain, that the intracellular
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Figure 5. Role of the Extracellular and Intracellular Domains of
CD8b for the Intrathymic Generation of CD81 T Cells
Three-color immunofluorescence and flow cytometry was per-
Figure 4. CD8b Promotes LAT and Lck Association to CD8 and formed on thymocytes from CD8b1/1 (B6) mice, CD8b0 mice, or
Promotes CD8 Signaling Function CD8b0 mice expressing the indicated transgenes. Note that the anti-
(A) Thymocytes were prepared from CD8b1/1 (B6), CD8b0 mice, or CD8a.2 mAb used in these experiments only binds to endogenous
from CD8b0 mice expressing the indicated transgene and assessed CD8a.2 molecules and does not bind to the transgenic molecules
for CD8a-associated Lck and CD8a-associated LAT by immunopre- expressed by the aaa or abb transgenes. Two-color contour plots
cipitation and immunoblotting. Aliquots of cell lysates were immu- for anti-CD8a.2 and anti-CD4 staining are shown; the numbers in
noblotted in parallel to assess total cell contents of Lck and LAT. the analysis windows indicate the percentage of cells present in
(B) Decreased CD8 signaling capabilities in the absence of CD8b. that box. Numbers of TCRhiCD81 T cells were determined by multi-
Purified CD4181 thymocytes were stimulated by TCR 1 CD4 co- plying the percentage of total thymocytes that were TCRhiCD428a.21
cross-linking, TCR 1 CD8 cocross-linking, or TCR co-cross-linking cells by the total number of viable cells. Thymocyte numbers are
alone and detergent solubilized with Triton X-100. Lysates were derived from 3±9 individual mice analyzed in 3±7 separate experi-
immunoprecipitated and immunoblotted with an anti-phosphotyro- ments and represent the mean 6 SEM. An asterisk indicates strains
sine mAb. Quantification of ZAP70 and TCRz tyrosine phosphoryla- where the number of TCRhiCD428a.21 thymocytes was significantly
tion revealed that phosphorylation induced by TCR 1 CD4 co-cross- greater than that in CD8b0 mice (p , 0.05 by one-tailed Student's
linking was equivalent in CD8b0 and CD8b1/1 thymocytes (lanes 3, t test).
7), but that phosphorylation induced by TCR 1 CD8 co-cross-linking
was reduced by 60% in CD8b0 thymocytes relative to CD8b1/1 thy-
mocytes (lanes 4 and 8). extracellular and intracellular domains of CD8b can in-
dependently enhance CD8 coreceptor function for CD81
T cell differentiation, but that both domains together aredomain of CD8b can promote CD8 coreceptor function
most effective. Thus, CD8b enhances two categoriesin the absence of the CD8b extracellular domain, but that
of protein±protein associations that form the molecularboth CD8b domains are required for full CD8 coreceptor
bases for CD8 coreceptor function. In fact, these experi-activity.
ments indicate that CD8 surface complexes can be
viewed as consisting of independent intracellular andDiscussion
extracellular protein modules and that both CD8a and
CD8b components are required for efficient functioningThe present study was initiated to understand how
of each protein module.CD8b, which may not directly bind to extracellular MHC
I molecules or to intracellular signaling molecules, nev-
ertheless enhances CD8 coreceptor function. The key Role of CD8b Extracellular Domain
in CD8/MHC Interactionsfindings of the present study are that (1) the extracellular
domain of CD8b significantly enhances CD8 binding to Using a novel tetramer-based assay, the present study
demonstrates that MHC I binds with greater avidity toextracellular MHC I molecules, (2) the intracellular do-
main of CD8b significantly enhances CD8 binding to Lck CD8ab surface complexes than to CD8aa surface com-
plexes and that this function of CD8b is mediated byand LAT intracellular signaling molecules, and (3) the
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because binding of MHC I tetramers to surface CD8
complexes is inhibited by anti-CD8 mAbs, tetramer
binding to CD8 would be blocked if cells were costained
with anti-CD8 mAbs. In any event, our findings that the
H-2Dk MHC I tetrameric complexes bind to TCRa0 thy-
mocytes and to CD8ab2expressing HeLa cells unam-
biguously demonstrates that they specifically bind to
CD8 surface complexes.
The question of whether CD8b promotes MHC I bind-
ing to CD8 complexes had been previously addressed
using either plasmon resonance to directly measure
MHC I binding to recombinant CD8 molecules (Garcia
et al., 1996; Kern et al., 1999; Wyer et al., 1999) or cell
adhesion assays to indirectly measure MHC I/CD8 inter-
action (Norment et al., 1988; Sun and Kavathas, 1997).
Interestingly, both types of analyses failed to reveal sig-
nificant differences in MHC I binding avidity between
CD8ab and CD8aa complexes. However, both types
of analyses have significant limitations. Cell adhesion
assays required marked overexpression of CD8 to de-
tect any CD8/MHC I interactions and only provided an
indirect reading of MHC I/CD8 binding. Plasmon reso-
nance analyses were necessarily performed on CD8aa
and CD8ab dimers that lacked both their interchain di-
sulphide bonds and their plasma membrane attach-
ments, so that CD8 conformation in these assays would
be significantly different from that of CD8 complexes
on the surface of cells. In fact, our present observation
that the CD8b extracellular domain contributes to MHC
Figure 6. The Extracellular and the Intracellular Domains of CD8b I binding by CD8 surface complexes is supported by
Independently Promote Positive Selection of CD8 T Cells Expressing our in vivo finding that the CD8b extracellular domain
the HY TCR significantly promotes CD81 T cell differentiation in the
Thymocytes were prepared from female HY TCR CD8b0 mice or thymus.
from HY TCR transgenic CD8b0 mice expressing the indicated CD8aa/MHC I complexes have been shown by X-ray
transgenes, and were analyzed by three-color immunofluorescence
crystallographic studies to consist of one MHC/peptideand flow cytometry with mAb against CD8a.2, CD4, and the clono-
complex bound to a homodimer of two CD8a Ig-liketypic HY TCR (T3.70). Shown are two-color contour plots for CD8a.2
domains (Gao et al., 1997; Kern et al., 1998). In contrastand CD4 staining. T3.70hiCD428a.21 thymocytes are expressed both
as percent of total thymocytes and absolute numbers of cells. Num- to CD8aa /MHC I complexes, the structure of CD8ab/
bers are averages 6 SEM and are derived from 2±5 individual mice. MHC I complexes is not yet known. Nevertheless, there
are two different structural models that can account for
enhanced MHC I binding by CD8ab complexes relative
the CD8b extracellular domain. CD8/MHC I interactions to CD8aa complexes. In the first model, CD8b simply
measured by this assay are specific, as demonstrated contributes contact residues that bind to sites on MHC
by the facts that (1) MHC I tetramer binding is only I with greater avidity than corresponding contact resi-
observed on CD81 cells and not on CD82 cells, (2) CD8 dues on CD8a chains. In the second model, each chain
expression is both necessary and sufficient for binding in the CD8aa homodimer sterically interferes with MHC
of MHC I tetramers, and (3) MHC I tetramer binding is I binding by the other chain. This is avoided in CD8ab
inhibited by antibody-mediated blockade of CD8 mole- complexes because the shorter extracellular domain of
cules. CD8b does not sterically interfere with MHC I binding
In contrast to the present study, binding of MHC I by its partner CD8a chain. Future experiments will be
tetramers to surface CD8 complexes was not noticed directed at determining the actual structure of CD8ab/
in earlier analyses in which MHC I tetramers were found MHC I complexes.
to bind to surface TCR complexes (Altman et al., 1996).
We think that there are several explanations for this Role of the CD8b Intracellular Domain in CD8
discrepancy. First, indicative of a relatively low-affinity Binding to Intracellular Signaling Molecules
interaction with a rapid dissociation rate, MHC I tetra- The present study demonstrates that the CD8b intracel-
mers bound to surface CD8 complexes far more effi- lular domain enhances CD8a association with two mole-
ciently at 4oC than at 37oC, whereas clonotypic binding cules instrumental for transduction of TCR signals, Lck
to surface TCR complexes is most frequently assessed and LAT. While it had previously been shown that Lck
at 37oC (Whelan et al., 1999). Second, only three of five binding to CD8a was decreased in the absence of the
of the MHC I tetrameric complexes that we examined CD8b intracellular domain (Irie et al., 1995, 1998), the
bound to surface CD8 complexes, presumably because present study demonstrates that this is also the case
the three-dimensional folding of different MHC I tetramer for LAT. The present study also confirms that CD8 com-
plexes specifically lacking the CD8b intracellular domaincomplexes affects their ability to bind to CD8. And third,
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did not bind Lck or LAT with greater efficiency than as proposed in previous reports (Itano et al., 1994; Irie
et al., 1998), but are in fact partially active CD8b proteinsCD8aa complexes in CD8b0 thymocytes. Importantly,
that promote positive selection of significant numbersthe present report extends these previous studies by
of CD81 T cells.demonstrating that expression of the abb transgene in
Signaling by coreceptor cytosolic tails has beenCD8b0 thymocytes restored Lck and LAT binding to
shown to play an important role during intrathymic TCD8a to levels observed in wild-type thymocytes. Thus,
cell differentiation, as tailless versions of CD4 and CD8a,the present study demonstrates that the CD8b intracel-
which do not bind Lck or LAT, exhibit markedly impairedlular domain exerts a positive effect on Lck and LAT
coreceptor functions during T cell differentiation (Fung-binding to the CD8a intracellular domain and does more
Leung et al., 1993; Killeen and Littman, 1993). In addition,than preventing steric interference between adjacent
previous studies from this laboratory also demonstratedCD8a intracellular domains within CD8aa dimers. In fact,
that, in in vitro signaling experiments, initiation of TCRpositively charged residues within the CD8b tail may
signaling in double-positive thymocytes required coen-interact with negatively charged residues in Lck and so
gagement of CD4 and CD8 coreceptor molecules withstabilize Lck binding to the CD8a tail.
TCR complexes and could not be readily achieved in
fresh double-positive thymocytes by TCR engagementImplications for CD8 Coreceptor Function
alone (Wiest et al., 1996). Extending the findings of anTwo key findings of the present study are that both the
earlier report (Irie et al., 1998), the present study bringsextracellular and intracellular domains of CD8b contrib-
new support for the idea that coreceptor signaling isute to CD8 coreceptor function and that each of them
essential for positive selection, as the present studycan independently promote CD8 function to some ex-
shows that decreased association of Lck and LAT totent. Indeed, positive selection of CD81 T cells by the
CD8 coreceptor molecules results in reduced generationHY TCR was enhanced by the bb0 transgene, which
of CD81 T cells in the thymus.encodes a CD8b protein lacking its intracellular domain,
While all thymically derived CD81 T cells expressas well as by the abb transgene, which encodes a CD8
CD8ab surface complexes, there exist populations ofchimeric protein with the CD8b intracellular domain. In-
CD81 T cells that only express CD8aa homodimers andterestingly, simultaneous expression of both abb and
that are independent of classical MHC I moleculesbb0 transgenes in individual HY TCR CD8b0 mice did
(Goodman and Lefrancois, 1988; Baume et al., 1990;not improve selection of HY CD8 T cells over what is
Guy-Grand et al., 1991; Rocha et al., 1991; Das andobserved in mice separately expressing either abb or
Janeway, 1999; Park et al., 1999). The present study
bb0 transgene (data not shown), suggesting that both
shows that, relative to CD8ab complexes, CD8aa com-extracellular and intracellular CD8 components have to
plexes have both decreased ability to interact with clas-be present within the same CD8 complex or in the same
sical MHC I molecules and decreased signaling abilitymolecule for efficient CD8 coreceptor function.
as a result of their decreased association with Lck andThe present study indicates that the avidity of CD8/
LAT. Thus, the present study points to the existenceMHC I interactions is determinant for CD8 coreceptor
of two categories of CD8 complexes: ªhigh efficiencyº
function. That is, CD8 complexes that bind MHC I mole-
CD8ab complexes and ªlow efficiencyº CD8aa com-
cules with reduced avidity have decreased CD8 core-
plexes. In addition, by showing that two distinct domains
ceptor function. This conclusion contrasts with a model of CD8b strengthen the molecular associations that un-
proposed by Wyer et al. from their in vitro plasmon derlie CD8 coreceptor function, the present study also
resonance measurements of CD8/MHC I interactions suggests that CD8 complexes are made of two physi-
(Wyer et al., 1999). Because of the instability of CD8/ cally linked protein modules that can function indepen-
MHC I complexes, it was argued that significant binding dently from each other: an extracellular protein module
of CD8 to MHC I/peptide complexes could only occur responsible for MHC I binding and an intracellular pro-
after MHC I/peptide complexes were bound to surface tein module responsible for association with signaling
TCR complexes. In this model, CD8 surface complexes molecules.
are recruited to MHC I±engaged TCR complexes by in- In conclusion, the present study indicates that CD8
tracellular binding of CD8-associated Lck molecules to coreceptor function depends upon the ability of CD8
TCR associated ZAP-70 molecules (Thome et al., 1996; surface complexes to bind to extracellular MHC I mole-
Ashe et al., 1999). Thus, the major contribution of CD8b cules and to associate with intracellular Lck and LAT
to CD8 coreceptor function would be to promote intra- molecules and that the role of CD8b is to promote bind-
cellular associations with Lck and would not involve the ing of both categories of molecules.
CD8b extracellular domain. Contrary to this perspective,
Experimental Proceduresthe present study demonstrates that the CD8b extracel-
lular domain significantly contributes to CD8 function.
MiceThe contribution of the CD8b extracellular domain to
C57BL/6 (B6) mice were purchased from the Jackson Laboratory
CD8 function does not at all mean that the CD8b intracel- (Bar Harbor, ME); CD8b0 mice were obtained from Dr. Dan Littman
lular domain is without function, as was recently sug- (NYU Medical Center, New York, NY) and were bred in our own
animal facility (Crooks and Littman, 1994). All mice used in the pres-gested (Witte et al., 1999). To the contrary, the present
ent study were housed in a specific pathogen-free facility and werestudy formally establishes that the CD8b intracellular
cared for in accordance with National Institutes of Health guidelines.domain independently promotes CD8 coreceptor func-
tion, even in the absence of the CD8b extracellular do- Generation and Identification of Transgenic Mice
main. Moreover, CD8b molecules that lack an intracellu- cDNAs encoding mouse CD8a.2 and CD8b.2 molecules were gener-
ously provided by Dr. Jane Parnes (Stanford University, Stanford,lar domain are not dominant-negative versions of CD8b,
Immunity
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CA). Fragments encoding each coreceptor domain, or mutant deriv- complexes with allophycocyanin (APC)-conjugated streptavidin as
described (Altman et al., 1996). For staining, thymocytes (106) wereatives thereof, were prepared by restriction enzyme digestion, PCR
amplification, or as double-stranded oligonucleotides, and ligated distributed in 5 ml tubes and, unless otherwise indicated, were kept
at 4oC throughout the procedure. After washing, cells were resus-to generate the indicated constructs. The original CD8a.2 cDNA
was converted to the CD8a.1 allele by mutating codon 105 from ATG pended in 100 ml final volume of cold staining medium (0.5% BSA,
0.5%NaN3 in HBSS), incubated for 1 hr with APC-conjugated H-2Dk(methionin) to GTG (valine) by PCR-mediated mutagenesis (Landt et
al., 1990). The predicted amino acid sequence (single letter code) tetramers at a final concentration of H-2Dk of z40 mg/ml, and then
washed twice again. Where indicated, cells were subsequentlyat the CD8a/CD8b junction of the abb cDNA product is as follows:
LDFACD/ITCSLTT. Both the bbb and bb0 cDNAs are truncated ver- stained with FITC-conjugated anti-CD8a (53.6±7) and anti-CD4
(GK1.5) mAbs and washed again. In antibody-blocking experiments,sions of the wild-type CD8b.2 cDNA that lack the noncoding region
39 of nucleotide 760 (Nakauchi et al., 1987). The bb0 cDNA includes thymocytes were first incubated with 1 mg of anti-CD8a (53.6±7) or
anti-CD8b (53±5.8) prior to tetramer binding. Where indicated, MHCan AGA!TGA mutation at codon 202 that results in the premature
termination of translation at codon 201. Sequences of all PCR-ampli- I tetramers were incubated with thymocytes for 1 hr at 37oC. Cells
were then transferred at 4oC and immediately washed to removefied and oligonucleotide-encoded regions were verified by dideoxy
sequencing for the presence of the desired modifications and the unbound tetramers. All washes were performed at 4oC, regardless
of the temperature used for the binding reaction. Cell fluorescenceabsence of additional mutations. Transient transfection in HeLa cells
verified the expression of wild-type and mutant cDNAs and demon- was typically measured on 1.25 3 105 cells using either a FacStar
Plus or a FacsVantage SE (Becton Dickinson) and analyzed withstrated that the bbb- and bb0-encoded products required coexpres-
sion of wild-type CD8a proteins to be expressed on the cell surface. software designed by the Division of Computer Research and Tech-
nology at the National Institutes of Health. Dead cells were excludedIn contrast, the product of the abb transgene did not require CD8a
coexpression for cell surface expression. Mutant and wild-type from analysis by electronic gating on forward scatter light and pro-
pidium iodide staining.cDNAs were introduced into a human CD2 (hCD2)-based vector
(Greaves et al., 1989; Love et al., 1994; Shores et al., 1994) for
the generation of transgenic mice. Fragments containing the hCD2
Antibodiestranscription control regions and the inserted cDNAs were excised
The following mAbs were used for immunofluorescence and flowfrom the plasmid backbone by restriction enzyme digestion, purified
cytometry: anti-CD4 (GK1.5, Collaborative Bioproducts); anti-CD8aby sucrose gradient centrifugation, and microinjected in fertilized
(53.6±7, Collaborative Bioproducts), anti-CD8a.2 (2.43, SarmientoFVB/N oocytes as described (Brinster et al., 1985). Founder mice were
et al., 1980), anti-CD8b (53±5.8, PharMingen); anti-TCRb (H57±597,identified by Southern blotting on tail DNA. Transgenic (FVB/N 3
Pharmingen), and anti-HY TCR (T3.70, Teh et al., 1989). The followingB6) F1 offsprings were backcrossed to CD8b0 mice three to five
mAbs were used for immunoprecipitation: anti-CD8a (53.6±7, Phar-times before analysis. Surface expression of the transgenic proteins
Mingen), anti-phosphotyrosine (4G10, UBI, Lake Placid, NY). Thein association with endogenous CD8a.2 molecules was confirmed
following antibodies were used for immunoblotting: anti-LAT (serumby anti-CD8a.2 immunoprecipitation of lysates from surface biotinyl-
3023) (Zhang et al., 1998), anti-Lck (serum 688), and anti-phospho-ated thymocytes (data not shown). In addition, efficient pairing of
tyrosine (4G10). mAbs used for anti-CD8a immunoprecipitationsabb molecules with endogenous CD8a molecules was demon-
were directly coupled to CnBr-activated Sepharose beads (Phar-strated by the significantly increased ability of the abb transgene
macia).(but not the aaa transgene) to quantitatively restore Lck and LAT
binding to endogenous CD8a molecules. CD8b0 mice expressing
the various transgenes were identified by immunofluorescence and Immunofluorescence and Flow Cytometry
flow cytometry on peripheral blood lymphocytes or by PCR of tail Analyses of T cell populations by surface staining and flow cytome-
DNA. Oligonucleotides used for PCR detection of the bbb or bb0 try were performed at 4oC as described (Punt et al., 1996). In brief,
transgenes were as follows: 59 primer, 59-cagccttaccaccctcagc thymocytes (5 3 105) were distributed in 96-well microtiter plates,
ctg-39; 39 primer, 59-ctgccagccctcttccatc-39. Oligonucleotides used for washed three times with cold staining medium, and stained with
PCR detection of the CD8b wild-type allele were as follows: 59 biotinylated anti-CD8a.2, PE-conjugated anti-CD4, and FITC-conju-
primer, 59-aagtactttgagttcctggcc-39; 39 primer, 59-gtgctcattcacag gated anti-TCRb mAbs. In addition, some experiments were per-
ccttgag-39. All transgenic mice used in the present study were het- formed using FITC-conjugated anti-CD8a.2, PE-conjugated anti-CD4,
erozygous for the transgene they expressed. Control CD8b0 mice and biotinylated anti-TCRb mAbs. For analyses of T cell differentia-
were littermates of transgenic animals. tion in HY TCR transgenic mice, FITC-conjugated T3.70 was used
instead of anti-TCRb. Cells were washed twice after staining and
further stained with Cy-5-conjugated streptavidin.Cell Preparation
Single-cell suspensions of thymocytes were prepared by gentle
teasing of thymi isolated from 6- to 12-week-old mice. Purified popu-
Immunoprecipitations and Thymocyte Stimulationlations of CD4181 thymocytes were prepared from B6 or CD8b0
For immunoprecipitations, thymocytes (108) were lysed in ice-coldmice by anti-CD8 panning of whole thymocyte populations and
lysis buffer containing 1% Triton X-100. After clarification (10000 3 gselecting the adherent cells, as previously described (Nakayama et
for 10 minutes), cell lysates were immunoprecipitated with the indi-al., 1989b). For transient transfection experiments, HeLa cells were
cated antibodies. Immunoprecipitates were resolved on SDS-PAGEtransfected using the calcium-phosphate method (Graham and van
under reducing conditions, transferred to PDVF membranes, andder Eb, 1973; Bosselut et al., 1999) and analyzed by immunofluores-
immunoblotted. For TCR cross-linking experiments, purified CD4181cence and flow cytometry 40 hr later.
thymocytes (5 3 107) were resuspended at 107/ml in ice-cold RPMI
containing 1 mM Na3VO4 and biotinylated antibodies (10 mg/ml).
MHC I Tetramer Binding Analyses After 10 min at 48C, the cells were pelleted and resuspended at 108/ml
The following MHC I tetramers were used in the present study: in RPMI containing 20 mg/ml streptavidin (Southern Biotechnology
H-2Dk/MT389 (Wilson et al., 1999); H-2Db/gp33, H-2Ld/NP118 (Mu- Associates) previously prewarmed at 378C. After a 5 min incubation
rali-Krishna et al., 1998); and Qa1/Qdm and H-2Kd/CW3 (both a gift at 378C, cells were pelleted and lysed in TX-100 containing buffer.
from Dr. P. Kourilsky, Institut Pasteur, Paris, France). Initial experi-
ments showed that H-2Dk/MT389, H-2Db/gp33, and Qa1/Qdm bind
to .50% of total thymocytes (data not shown). H-2Dk tetramers Acknowledgments
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